Advertisement
Advertisement

IMTX

IMTX logo

Immatics N.V

6.86
USD
-0.32
-4.46%
Dec 18, 14:59 UTC -5
Open

Immatics N.V Profile

About

Immatics N.V. engages in the discovery of targets for cancer immunotherapies. It is developing targeted immunotherapies with focus on treating solid tumors. Immatics N.V., formerly known as ARYA SCIENCES, is based in Tuebingen, Germany.

Info & Links

CEO

Harpreet Singh

Headquarters

PAUL EHRLICH-STRASSE 15
TUBINGEN, 2M 72076, GERMANY

Auditor

PricewaterhouseCoopers

Share holders

44

Employees

343

Immatics N.V Statistics

Valuation Measures

Market Capitalization2

818.81M

Enterprise Value

648.51M

Enterprise Value/EBITDA(ttm)

-6.56

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

6.84

Price to Book(mrq)

2.05

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-47.94%

Profit Margin(ttm)

-71.88%

Return on Equity(ttm)

-15.90%

Return on Invested Capital(ttm)

-19.19%

Return on Assets(ttm)

-9.38%

Income Statement

Revenue(ttm)

76.61M

Revenue Per Share(ttm)

--

Gross Profit(ttm)

76.61M

EBITDA(ttm)3

-98.93M

Net Income Available to Common(ttm)

-79.67M

Diluted EPS(ttm)

-0.66

Share Statistics

Beta (5Y Monthly)

0.74

52-Week Change

-25.35%

S&P 500 52-Week Change

26.34%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

0.00

% Held by Insiders

--

% Held by Institutions

64.41%

Balance Sheet

Total Cash(mrq)

170.30M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

3.98%

Quick Ratio(mrq)

3.98%

Book Value Per Share(mrq)

4.08

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.99

Free Cash Flow(ytd)

-125.52M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement